Method for estimating the physiological parameters defining the edema induced upon infusion of fluid from an intraparenchymally placed catheter
Abstract
A method for estimating the physiological parameters defining the edema induced upon infusion of fluid from an intraparenchymally placed catheter including; a) acquisition of patient-specific medical data; b) estimation of pertinent tissue microstructure based on the patient-specific medical data and/or generalized information derived or drawn from one or more of the following: experience, literature, modeling, studies, research, analysis; c) acquisition of information about delivery parameters, and/or delivery device geometry, and/or fluid properties, such as: delivery device trajectory, flow rate, pressure, catheter diameter, catheter profile, fluid viscosity, fluid molecular size; and d) computing a field of values of predicted extracellular volume fraction over the tissue region using the information obtained in (b) and (c). According to a further aspect, a method of infusing or planning and/or monitoring an infusion of a contrast agent such that the distribution of such agent can be detected by means of medical data acquisition (e.g. MRI, CT, x-ray, ultrasound, SPECT, PET) and observing and/or measuring the backflow length along the catheter track.
Claims
exact text as granted — not AI-modified1 . A method for estimating the physiological parameters defining the edema induced upon infusion of fluid from an intraparenchymally placed catheter including;
a) acquisition of patient-specific medical data; b) estimation of pertinent tissue microstructure based on the patient-specific medical data and/or generalized information derived or drawn from one or more of experience, literature, modeling, studies, research, and/or analysis; c) acquisition of information about delivery parameters, and/or delivery device geometry, and/or fluid properties; and d) computing a field of values of predicted extracellular volume fraction over the tissue region using the information obtained in (b) and (c).
2 . The method of claim 1 , wherein the patient-specific medical data includes one or more of MRI, CT, PET, SPECT, and/or x-ray data.
3 . The method of claim 1 , wherein the tissue microstructure includes information about crossing and intra-voxel directionality of fibers in white matter.
4 . The method of claim 1 , wherein patient-specific medical data includes one or more of diffusivity of water molecules, capillary permeability, blood flow, and/or blood volume.
5 . The method of claim 1 , wherein any of the computations include one or more of the following parameters: pore fraction, intracellular volume fraction, extracellular volume fraction, and/or hydraulic conductivity.
6 . The method of claim 1 , wherein the diffusivity of water molecules within the measurement volume is computed.
7 . The method of claim 1 , wherein the directionality of extracellular matrix scaffolding with respect to the cellular fiber directions is estimated.
8 . The method of claim 7 , wherein the tautness or slackness of the extracellular matrix scaffolding is estimated.
9 . The method of claim 1 , wherein patient-specific medical data and/or generalized information is used to extract regions and/or structures of special relevance to the procedure, including one or more of surfaces, functional areas, nerve fiber tracks, cavities, and/or intracranial structures that influence fluid flow and/or distribution.
10 . The method of claim 9 wherein the extraction of regions and/or structures is performed automatically or semi-automatically using models and/or algorithms for surface detection and delineation, atlases, anatomical information, and computerized versions thereof.
11 . The method of claim 1 , wherein a derivation of reference values refer to literature values and/or properties about the target volume and/or the entire measurement volume of the patient specific medical information.
12 . The method of claim 1 , wherein a derivation of reference values refer to a model for fluid distribution within tissue.
13 . The method of claim 1 , wherein a derivation of reference values refer to generalized values derived from a database.
14 . The method of claim 1 , wherein an extracellular volume is measured by using medical images.
15 . The method of claim 14 , wherein the extracellular volume is measured automatically by using imaging processing algorithms.
16 . The method of claim 15 , wherein the algorithms are specially adapted to properties of the contrast agents.
17 . The method claim 1 , wherein the result of extracellular expansion estimation is used to refine an infusion or an infusion plan or the information used within the procedure.
18 . The method of claim 17 , wherein the refinement is done automatically and is implemented in software.
19 . The method of claim 1 whereby the information computed is used to estimate the location of points at which migrating cells are likely to settle.
20 . The method of claim 1 , whereby the expansion of the extracellular volume of tissue is used for one or more of the following:
i. simulating pressure fields and/or fluid concentration and/or flow parameters, ii. determining suitability of catheter placement for infusing an agent into tissue, and/or iii. repeating one or more of the steps of claim 1 using altered methods and/or devices and/or fluids and/or data.
21 . The method of claim 1 , wherein the information about delivery parameters, and/or delivery device geometry, and/or fluid properties, includes one or more of delivery device trajectory, flow rate, pressure, catheter diameter, catheter profile, fluid viscosity or fluid molecular size.
22 . A method of planning and/or monitoring an infusion of a contrast agent such that the distribution of such agent can be detected by means of medical data acquisition and observing and/or measuring the backflow length along the catheter track.
23 . The method of claim 22 wherein, the extracellular volume is measured by using medical images.
24 . The method claim 23 , wherein the extracellular volume is measured automatically by using imaging processing algorithms.
25 . The method of claim 22 , wherein the algorithms are specially adapted to properties of the contrast agents.
26 . The method of claim 22 , wherein the result of extracellular expansion estimation is used to refine the infusion or the infusion planning or the information used within the procedures described in claims 1 to 13 .
27 . The method of claim 26 , wherein the refinement is done automatically and is implemented in software.
28 . The method of claim 22 , wherein the information computed is used to estimate the location of points at which migrating cells are likely to settle.
29 . The method of claim 22 , wherein the expansion of the extracellular volume of tissue is used for one or more of the following:
i. simulating pressure fields and/or fluid concentration and/or flow parameters, ii. determining suitability of catheter placement for infusing an agent into tissue, and iii. repeating one or more of the steps of claim 1 using altered methods and/or devices and/or fluids and/or data.
30 . A method of infusing a contrast agent such that the distribution of such agent can be detected by means of medical data acquisition and observing and/or measuring the backflow length along the catheter track.
31 . The method of claim 30 , wherein extracellular volume is measured by using medical images.
32 . The method claim 31 , wherein the extracellular volume is measured automatically by using imaging processing algorithms.
33 . The method of claim 32 , wherein the algorithms are specially adapted to properties of the contrast agents.
34 . The method of claim 30 , wherein the result of extracellular expansion estimation is used to refine the infusion or the information used within the procedure.
35 . The method of claim 34 , wherein the refinement is done automatically and is implemented in software.
36 . The method of claim 30 , wherein the information computed is used to estimate the location of points at which migrating cells are likely to settle.
37 . The method of claim 30 , wherein the expansion of the extracellular volume of tissue is used for one or more of the following:
i. Simulating pressure fields and/or fluid concentration and/or flow parameters, ii. determining suitability of catheter placement for infusing an agent into tissue, and iii. repeating one or more of the steps of claim 1 using altered methods and/or devices and/or fluids and/or data.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.